EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Douglas Connect (3 days ago)
RT @barryhardy: Do want an exciting career journey for 2019? Help advance the development and application of #Safety #Assessment Products d…
Douglas Connect (2 weeks ago)
Some of our most powerful modern pharmaceuticals come from nature. However, we are still nowhere near making full u… https://t.co/xPbh8qgsFB
Douglas Connect (2 weeks ago)
RT @barryhardy: Collaborative Developments on new methods #Safety #assessment #toxicology #risk #healthcare #environment at the National Co…
Douglas Connect (3 weeks ago)
We are looking for a strategic marketing leader to join the DC team - looking for a strong and dedicated knowledge… https://t.co/RDtLzKs4bL
Douglas Connect (3 weeks ago)
Register now to the hands-on training on #InVitro flow systems & #FAIR data integration for #SafetyAssessment Early… https://t.co/Hhu0kmE3U2

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com